Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MDM2 interacts with and downregulates a sarcomeric protein, TCAP.

Li-Feng Tian1, Hui-Yan Li, Bao-Feng Jin

  • 1National Center of Biomedical Analysis, Beijing 100850, China.

Biochemical and Biophysical Research Communications
|May 9, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rising tides: Unveiling the spatial and temporal evolution of sea level rise under climate change.

PloS one·2026
Same author

Multicenter external validation of the FW-TRIC score for predicting red blood cell transfusion in on-pump cardiac surgery.

Perioperative medicine (London, England)·2026
Same author

Digital first primary care in NHS England: evaluating alignment with patient-centered care and implications for future practice.

Frontiers in digital health·2026
Same author

Experimental Study on Seepage and Heat Transfer Patterns of Hot Water in Fractured Coal.

ACS omega·2026
Same author

Sex as a Contextual Modifier in Colorectal Cancer: Integrating Tumor Sidedness, Molecular Subtype, Immune Ecology, and Early-Onset Disease.

Cancers·2026
Same author

Laparoscopic partial hepatectomy for primary hepatic PEComa: a case report.

BMC gastroenterology·2026

The E3 ubiquitin ligase MDM2 targets TCAP for degradation, potentially linking MDM2

Area of Science:

  • Molecular Biology
  • Cardiovascular Research

Background:

  • MDM2 (mouse double minute 2 homolog) is reported to attenuate cardiac myocyte hypertrophy.
  • The precise mechanism by which MDM2 influences cardiac hypertrophy remains unclear.

Purpose of the Study:

  • To identify novel MDM2-binding proteins involved in cardiac hypertrophy.
  • To elucidate the mechanism of MDM2-mediated regulation of TCAP.

Main Methods:

  • Yeast two-hybrid screening to identify MDM2-interacting proteins.
  • GST pull-down and co-immunoprecipitation assays for validation.
  • Confocal microscopy for subcellular localization studies.
  • Western blotting to assess protein levels and proteasomal degradation.
  • Inhibition studies using p14ARF.

Related Experiment Videos

Main Results:

  • TCAP (T-cap) was identified as a novel specific MDM2-binding protein.
  • MDM2 and TCAP co-localize in the nucleus, and MDM2 affects TCAP's subcellular distribution.
  • MDM2 downregulates TCAP protein levels via the proteasomal pathway, an effect inhibited by p14ARF.
  • TCAP degradation by MDM2 occurs through a ubiquitin-independent pathway.

Conclusions:

  • MDM2 interacts with and degrades TCAP, a key component in cardiac hypertrophy.
  • This MDM2-TCAP interaction, mediated by ubiquitin-independent proteasomal degradation, may play a role in MDM2's function in cardiac hypertrophy.
  • Further research is warranted to explore the biological significance of this interaction in cardiac hypertrophy.